From the last 100 to the first 100–outcome after a manufacturer change in reverse fracture arthroplasty
European Journal of Trauma and Emergency Surgery · 2025
DOI: 10.1007/s00068-024-02724-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Trauma and Emergency Surgery, 2025. Verfasst von Johannes Gleich und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM) University Hospital, LMU Munich, Marchioninistr. 15, 81…. Hauptthemen laut MEDLINE: Shoulder Fractures, Arthroplasty, Replacement, Shoulder, Shoulder Prosthesis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Klinikum der Universität München.
Abstract (Originalsprache)
Purpose
If surgery is indicated for elderly patients suffering a proximal humerus fracture, reverse fracture arthroplasty became the preferred type of treatment due to its good and reliable outcomes over the last decade. Surgeons could choose from a wide range of implants and up to now there was no evaluation, if a change of the manufacturer affects patients` outcome.
Methods
The last 100 patients before and the first 100 after manufacturer change in reverse fracture arthroplasty were evaluated at a level one trauma center, all treated by only 3 senior shoulder surgeons. Clinical as well as radiographic outcome parameters were assessed, perioperative up to 24 months after surgery.
Results
Mean age in both groups was nearly 80 years with comparable distribution of gender and comorbidities. A trend to shorter duration of surgery was observed after the change, mainly according to an uncemented fixation of the stem. During follow-up no significant differences, beneficial as well as negative, could be observed regarding clinical and radiographic outcome.
Conclusion
A manufacturer change on the fly is possible without negative consequences for patients` outcome. Expertise of the whole OR-team as well as standardized training with the new implant seems to be a more important factor than a specific type of implant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM) University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Johannes.Gleich@med.uni-muenchen.de.
- Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM) University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Förderung
- Klinikum der Universität München
Zitieren
APA
Gleich, J., Fleischhacker, E., Lampert, C., Siebenbürger, G., Ockert, B., Böcker, W., & Helfen, T. (2025). From the last 100 to the first 100–outcome after a manufacturer change in reverse fracture arthroplasty. European Journal of Trauma and Emergency Surgery. https://doi.org/10.1007/s00068-024-02724-3
Vancouver
Gleich J, Fleischhacker E, Lampert C, Siebenbürger G, Ockert B, Böcker W, et al. From the last 100 to the first 100–outcome after a manufacturer change in reverse fracture arthroplasty. European Journal of Trauma and Emergency Surgery. 2025. doi:10.1007/s00068-024-02724-3
BibTeX
@article{Gleich2025,
author = {Gleich, Johannes and Fleischhacker, Evi and Lampert, Christopher and Siebenbürger, Georg and Ockert, Ben and Böcker, Wolfgang and Helfen, Tobias},
title = {From the last 100 to the first 100–outcome after a manufacturer change in reverse fracture arthroplasty},
journal = {European Journal of Trauma and Emergency Surgery},
year = {2025},
doi = {10.1007/s00068-024-02724-3}
}
EUVIMED